Back to Authors

Bhattarai, Shanta

Mayo Clinic

The University of Texas MD Anderson Cancer Center

Citations 1

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer

Nanoscale | October 19, 2021 | Volume: 13 | Issue: 45 | Pages: 19056-19065

10.1039/d1nr05385j | PMID 34757363

CXC chemokine receptor 4 (CXCR4) is overexpressed on most breast cancer cell surfaces including triple negative breast cancer (TNBC) which lacks traditional receptor overexpression.